“…Presently, thirty-two natural abyssomicins have been identified, and numerous derivatives were synthesized [ 27 , 28 , 29 , 30 , 31 , 34 , 35 , 39 , 40 , 41 , 42 , 49 , 50 , 51 , 52 ]. Out of all the abyssomicins screened for antimicrobial activity, only four natural abyssomicins (abyssomicin 2, C, J and atrop-abyssomicin C) [ 27 , 28 , 29 , 30 , 35 ] and nine synthetic derivatives were active ( Table 1 and Table 2 ) [ 24 , 31 , 39 , 40 , 41 , 42 , 51 ]. Active abyssomicins against Gram-positive bacteria, including Micrococcus luteus , Bacillus thuringiensis , Enterococcus faecalis , MRSA, and vancomycin-resistant S. aureus (VRSA) strains are abyssomicin C and its atropoisomer, 4 atrop-abyssomicin C derivatives (Benzyl ether derivative, Chloro derivative, and two diastereoisomeric methoxymethyl (MOM) ethers derivatives), atrop-O-benzyl-desmethylabyssomicin C, oxidized derivative of abyssomicin I, acetyl abyssomicin C, 3-dithiolane atrop -abyssomicin C, and dithiolane abyssomicin C, and abyssomicin 2 ( Table 1 ) [ 30 , 31 , 32 , 33 , 34 , 37 , 42 , 51 , 57 ].…”